Henrik W.
- Country
- Germany
- Department
- n/a
Research Overview
- Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics of AZD8630 in Adults with Asthma on Medium-to-High Dose Inhaled Corticosteroids and Long-Acting Beta-Agonists
- Efficacy and Safety of Early Depemokimab Initiation as Add-on Therapy in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
- A Randomized, Double‑Blind, Placebo‑Controlled Phase 2/3 Study of Subcutaneous PF‑07275315 in Adults with Moderate‑to‑Severe Chronic Obstructive Pulmonary Disease
Data & Insights
Has run more than one trial at 151 of 381 partner sites.
Specializations
Respiratory Disease Management
The investigator specializes in treating various respiratory conditions, with particular emphasis on chronic obstructive pulmonary disease (COPD) and bronchiectasis. Their research encompasses evaluation of advanced therapeutic interventions for these chronic respiratory conditions.
- COPD Treatment Optimization
- Bronchiectasis Management
- Dynamic Hyperinflation Assessment
Asthma Studies
The investigator focuses on comprehensive asthma treatment approaches, particularly in cases of moderate to severe uncontrolled asthma. Their work includes evaluation of novel therapeutic agents and investigation of different treatment modalities.
- Uncontrolled Asthma Management
- Allergic Asthma Treatment
- Innovative Asthma Therapies
Allergic Conditions
The investigator's expertise extends to treating allergic rhinitis and rhinoconjunctivitis, with specific focus on conditions induced by house dust mite allergy. Their work includes evaluation of immunotherapy approaches for allergic conditions.
- House Dust Mite Allergy Treatment
- Immunotherapy Applications
- Combined Allergy Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.